There are only four companies in the world that have successfully commercialized Botox, but Korea has three: Medytox, Daewoong Pharmaceuticals and Hugel.
Health workers have been forced to open up a new and particularly perilous front after 28 people died of Ebola in and around Butembo, a city of approximately 1.2 million people that is located in the heart of the country’s most volatile regions.
In the past, Ebola outbreaks have been confined to isolated, rural areas, where they could be contained until they burned out. Now, the disease outbreak is in the second-most densely populated area of DRC.
Scientists have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. DMAbs may also provide a novel powerful platform for rapid screening of monoclonal antibodies enhancing preclinical development.
Health authorities have so far recorded 25,170 cases, occurring in 21 out of the Democrat Republic of Congo's 26 provinces.
Nine sheep and goats died from the anthrax, and seven human cases were also confirmed after about 35 people in the Siesfontein area consumed meat from stock that is suspected to have died from the disease.
Chinese authorities have announced strict new measures in an attempt to halt the country's fast-growing African swine fever crisis, which has spread to 18 provinces and led to the culling of more than 200,000 pigs.
Late blight is a huge problem for farmers, causing massive crop losses and proving difficult to manage by chemical control and traditional breeding methods. This new research is another milestone in the quest to provide potato breeders with the knowledge needed to develop disease-resistant varieties.
Fewer than one-in-10 countries have met global standards for securing high-consequence pathogens, increasing risks of an accidental disease outbreak or bioterrorism, a campaign group has warned. Just 19 countries completing a United Nations safety check have built or shown strong biosecurity safeguards.
Work on an engineered gene used to modify DNA of mosquitoes ‘could be stifled’ by perceived risk to environment. The United Nation’s Convention on Biological Diversity meeting in Egypt next week will consider recommendations that call on governments to refrain from releasing organisms that contain gene drives, even in small-scale field trials.